FIRM FIXED PRICENO SET ASIDE USED.
CEPHEID - MOLECULAR DIAGNOSTIC TESTING SYSTEM LEASE AND PURCHASE OF INSTRUMENT SPECIFIC ASSAYS
PIID: 36C26022P0781
Signed Date: Jan 28, 2026Effective Date: Aug 1, 2022End Date: Closed on Jul 31, 2025
Award $
$2.3M
Vendor
CEPHEID
NAICS
325413
Signed Date
Jan 28, 2026
Key Details
Description
MOLECULAR DIAGNOSTIC TESTING SYSTEM LEASE AND PURCHASE OF INSTRUMENT SPECIFIC ASSAYS
Context & Analysis
On Jan 28, 2026, Department of Veterans Affairs obligated $2,268,518.75 to CEPHEID for molecular diagnostic testing system lease and purchase of instrument specific assays. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in SUNNYVALE, CA. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325413 — related awards are listed below.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies
Vendors